News and Events
Our Latest News
Reprise Biomedical’s Miro3D® Wound Matrix Granted Level II HCPCS Code by CMS
FOR IMMEDIATE RELEASE: Monday, August 28, 2023 Reprise Biomedical’s Miro3D® Wound Matrix Granted Level II HCPCS Code by CMS Minneapolis, MN, August 28, 2023 – Reprise Biomedical, Inc., a leading innovator in medical biotechnology for wound care, is pleased to announce...
Miro3D named Top 10 Innovations in Podiatry
Miro3D wound matrix featured as a Top 10 Innovations in Podiatry, from Podiatry Today, click to read more from Raymond Abdo, DPM. Risk Info: https://reprisebio.com/miro3d-risk/
Reprise Biomedical Announces U.S. Launch of Miro3D® Three Dimensional Resorbable Wound Matrix
Unique three-dimensional biologic matrix is now available to treat deep and tunneling wounds Minneapolis, Minn. (October 6, 2022) – Reprise Biomedical, Inc., an innovative medical device company focused on developing and commercializing biologic solutions using its...
Reprise Biomedical now a corporate member of WOCN
Reprise Biomedical is pleased to announce that we have become a Corporate Member of the Wound, Ostomy, and Continence Nurses Society (WOCN). The WOCN Society is a professional community dedicated to advancing the practice and delivery of expert healthcare to...
Thanks to those who attended our webinar on Tuesday, January 19th 2021
Thanks to those who attended our webinar on Tuesday, January 19th 2021: Reducing Failure Rates in Hiatal and Paraesophageal Hernia Repair – the ‘Achilles Heel’ of Anti-reflux Surgery with Dr. G. Kevin Gillian. A full replay is available here. More information on...
The Florida Chapter, American College of Surgeons, and Reprise Biomedical are pleased to host a FREE Webinar
The Florida Chapter, American College of Surgeons, and Reprise Biomedical are pleased to host a FREE Webinar on Tuesday, January 19th, 2021 at 7:00 p.m. EST. Join us for a 45 min presentation followed by a Q&A session on “Reducing Failure Rates in Hiatal and...
Fall 2020 SAWC Virtual Meeting Poster Presentation
Recent Research from Reprise Biomedical will be Highlighted at the Fall 2020 SAWC Virtual Meeting Poster Presentation: Treatment of Hard-To-Heal Diabetic Foot Ulcers With A Hepatic-Derived Wound Matrix (HD-WM) By: Dr. Robert Fridman, DPM, FACFAS, CWSP, Columbia...
Newly Published June 2020 in Wounds Journal
Newly Published June 2020 in Wounds Journal: Treatment of Hard-to-heal Diabetic Foot Ulcers with a Novel Hepatic-Derived Wound Matrix. https://lnkd.in/eeMYNdn Read full article here: https://lnkd.in/efiXUkz For more info on MIRODERM: https://lnkd.in/esVgp-M
Reprise Biomedical supported MN healthcare workers
Reprise Biomedical supported MN healthcare workers by donating some of our extra personal protective equipment today. Our donation, with thoughtful inventory planning of what we could share, contributes to protecting our healthcare workers on the front lines today as...
Reprise Biomedical completes spin-off from Miromatrix Medical
New Minnesota-based medical device company focuses on biological medical devices manufactured using perfusion decellularization technology Minneapolis, Minn. (July 1, 2019) – Reprise Biomedical, Inc., a Minnesota-based startup focused on commercializing biological...
Medical Meetings
Reprise will be exhibiting at the following upcoming medical meetings:
| Jan 24-28 | Science & Management Symposium 2024 | Booth 816 | Orlando, FL |
| Feb 21-25 | Great Lakes Conference (MI Podiatric Medical Assn) | Booth TBD | Dearborn, MI |
| Feb 28-Mar 1 | Mayo Clinic Wound Symposium 2024 | Booth TBD | Rochester, MN |
| Mar 13-14 | CAMPs Wound Care Summit |
Booth 6 | Miami, FL |
| May 14-18 | Symposium on Advanced Wound Care (SAWC) Spring |
Booth 637 | Orlando, FL |
